chemotherapy-induced grade-4 thrombocytopenia
Showing 1 - 25 of >10,000
Non-Hodgkin Lymphoma Trial in Milano (Romiplostim)
Completed
- Non-Hodgkin Lymphoma
-
Milano, ItalyDip. Oncoematologia - Fondazione Centro San Raffaele del Monte T
Aug 10, 2022
Chemo-Induced Thrombocytopenia Trial (Hetrombopag)
Not yet recruiting
- Chemotherapy-Induced Thrombocytopenia
- (no location specified)
Jul 24, 2023
Chemo-induced Thrombocytopenia Trial (Hetrombopag)
Not yet recruiting
- Chemotherapy-induced Thrombocytopenia
- (no location specified)
Oct 20, 2023
Chemo-induced Thrombocytopenia Trial in Shanghai (QL0911)
Completed
- Chemotherapy-induced Thrombocytopenia
-
Shanghai, Shanghai, ChinaShanghai East Hospital
May 5, 2023
Chemo-Induced Thrombocytopenia Trial (Hetrombopag Olamine)
Not yet recruiting
- Chemotherapy-Induced Thrombocytopenia
- Hetrombopag Olamine
- (no location specified)
Jul 5, 2023
Chemo-Induced Thrombocytopenia Trial (Hetrombopag, Hetrombopag plus Placebo, Placebo)
Not yet recruiting
- Chemotherapy-Induced Thrombocytopenia
- Hetrombopag
- +2 more
- (no location specified)
May 17, 2023
Chemo-induced Thrombocytopenia, Herombopag Trial in Tianjin (Herombopag)
Recruiting
- Chemotherapy-induced Thrombocytopenia
- Herombopag
-
Tianjin, Tianjin, ChinaChinese Academy of Medical Science and Blood Disease Hospital
Jan 24, 2023
Chemo-induced Thrombocytopenia, Avatrombopag Trial in Tianjin (Avatrombopag)
Recruiting
- Chemotherapy-induced Thrombocytopenia
- Avatrombopag
-
Tianjin, Tianjin, ChinaChinese Academy of Medical Science and Blood Disease Hospital
Jan 24, 2023
Chemo-induced Thrombocytopenia, Eltrombopag Trial in Tianjin (Eltrombopag)
Recruiting
- Chemotherapy-induced Thrombocytopenia
- Eltrombopag
-
Tianjin, Tianjin, ChinaChinese Academy of Medical Science and Blood Disease Hospital
Jan 24, 2023
Chemo-induced Thrombocytopenia (CIT) Trial in Chengdu (Recombinant Human Tumor Necrosis Factor Receptor II -Fc-TPO Mimetic
Recruiting
- Chemotherapy-induced Thrombocytopenia (CIT)
- Recombinant Human Tumor Necrosis Factor Receptor II -Fc-TPO Mimetic Peptide Fusion Protein
-
Chengdu, Sichuan, ChinaWest China Hospital of Sichuan University
Jun 23, 2022
Chemo-induced Thrombocytopenia Trial in Shanghai (QL0911, Placebo)
Recruiting
- Chemotherapy-induced Thrombocytopenia
- QL0911
- Placebo
-
Shanghai, Shanghai, ChinaShanghai East Hospital
Sep 21, 2022
Thrombocytopenia Trial in Hefei (Avatrombopag)
Completed
- Thrombocytopenia
-
Hefei, Anhui, ChinaAnhui Provincial Cancer Hospital
Apr 24, 2022
Breast Cancer Trial in Zhengzhou (Hetrombopag, rh-TPO)
Not yet recruiting
- Breast Cancer
-
Zhengzhou, Henan, ChinaHenan Cancer Hospital
May 26, 2022
Gastrointestinal Cancer, Gastrointestinal Tumors, Chemo-Induced Thrombocytopenia Trial in Miami, Boston (Avatrombopag, Matching
Not yet recruiting
- Gastrointestinal Cancer
- +2 more
- Avatrombopag
- Matching Placebo
-
Miami, Florida
- +1 more
Mar 6, 2023
Chemotherapy Solid Tumors Who Receiving Thrombocytopenia
Completed
- Chemotherapy-induced Thrombocytopenia
- Recombinant Human Interleukin-11 for Injection
-
Shenyang, Liaoning, ChinaXing Xiaojing
Jan 15, 2023
Chemo-Induced Thrombocytopenia Trial (Hetrombopag, Matching )
Not yet recruiting
- Chemotherapy-Induced Thrombocytopenia
- Hetrombopag
- Matching placebo
- (no location specified)
Feb 21, 2022
NSCLC Trial (herombopag olamine tablets)
Not yet recruiting
- Non-small Cell Lung Cancer
- herombopag olamine tablets
- (no location specified)
Feb 14, 2022
Genomics and COVID-19 Vaccine Adverse Events
Recruiting
- Vaccine Adverse Reaction
- COVID-19 vaccines
-
Vancouver, British Columbia, CanadaBritish Columbia Children's Hospital Research Institute
Jun 24, 2022
Isolated Chemo-induced Thrombocytopenia Trial in United States (romiplostim)
Active, not recruiting
- Isolated Chemotherapy-induced Thrombocytopenia
- romiplostim
-
Basking Ridge, New Jersey
- +5 more
Feb 1, 2022
Chemo-induced Thrombocytopenia Trial in Worldwide (Romiplostim, Placebo)
Recruiting
- Chemotherapy-induced Thrombocytopenia
- Romiplostim
- Placebo
-
Jonesboro, Arkansas
- +114 more
Nov 11, 2022
Chemo-induced Thrombocytopenia Trial in Worldwide (Romiplostim, Placebo)
Recruiting
- Chemotherapy-induced Thrombocytopenia
- Romiplostim
- Placebo
-
Jonesboro, Arkansas
- +107 more
Feb 1, 2023
Anaplastic Astrocytoma, IDH-Wildtype, Anaplastic Oligoastrocytoma, Anaplastic Oligodendroglioma Trial in Houston (other,
Recruiting
- Anaplastic Astrocytoma, IDH-Wildtype
- +8 more
- Quality-of-Life Assessment
- +3 more
-
Houston, TexasM D Anderson Cancer Center
Dec 8, 2022
Chemo-Induced Nausea and Vomiting (CINV) Trial in Canton (SUSTOL)
Recruiting
- Chemotherapy-Induced Nausea and Vomiting (CINV)
-
Canton, OhioGabrail Cancer Center Research
Jul 15, 2022
Chemo-induced Thrombocytopenia Trial in Worldwide (Avatrombopag, Placebo Oral Tablet)
Active, not recruiting
- Chemotherapy-induced Thrombocytopenia
- Avatrombopag
- Placebo Oral Tablet
-
Anaheim, California
- +54 more
Nov 22, 2021